Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Understanding the Role of T Cells in CNS Homeostasis.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Tizanidine: Can Buy Uk
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Dimethyl fumarate protection against collagen II degradation.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
CombiRx for MS not better than monotherapy
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Gordon Research Conference on Notch Signaling in Development, Regeneration & Disease
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.

Pages